Page results
-
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
-
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
-
Court of Appeal has ruled in favour of the Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS).
-
Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).
-
An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%.
-
A new NHS vaccination centre at UCL’s Bidborough House, Bidborough Street, WC1H 9BT opened 26 August 2021.
File results
-
FOI/2023/0066 - Hospital catering - beef and poultry meat procured
-
FOI/2023/0068 - Intrapartum stillbirths, maternal deaths, neonatal deaths
-
FOI/2023/0069 - Operations waits for under-18s
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0086 - Number/ wait times for MRI scans for multiple sclerosis/ dementia/ prostate/ pancreatic cancer